| 000 | 01240 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514070146.0 | ||
| 264 | 0 | _c20030718 | |
| 008 | 200307s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.62.6.591 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHider, S L | |
| 245 | 0 | 0 |
_aWill pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with RA? _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cJun 2003 |
||
| 300 |
_a591; author reply 591-2 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xblood |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xgenetics |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 700 | 1 | _aMorgan, C | |
| 700 | 1 | _aBell, E | |
| 700 | 1 | _aBruce, I N | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 62 _gno. 6 _gp. 591; author reply 591-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.62.6.591 _zAvailable from publisher's website |
| 999 |
_c12546113 _d12546113 |
||